Rite Aid Pharmacy & Business News

Image description

Using multiple touchpoints to manage patient health

When news of Rite Aid’s acquisition of the $5 billion-large PBM EnvisionRx broke on Feb. 11, the company’s shares closed 6.6% higher that day at $8.08. That’s because Wall Street knows a good deal when it sees one, and the acquisition of EnvisionRx is a good deal.

Image description

Rite Aid’s SVP marketing discusses Plenti partnership

John Learish, SVP marketing for Rite Aid, explains Rite Aid's participation in what is a first for the U.S. retail industry: A coalition loyalty card program called Plenti that represents a partnership among several national iconic retail brands